Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages
2025 · 1st Quarter (Jan 1 - Mar 31)
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
Filed by PROFESSIONAL COMPOUNDING CENTERS OF AMERICA.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- Not reported
- Expenses
- $140,000.00
- Filing UUID
- 2ba3bb92-e220-4450-b244-d87cd3820398
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees
Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.